EMR - Emerson acquires life sciences company Fluxa no terms

• Emerson ( NYSE: EMR ) said on Thursday that it has acquired California-based Fluxa for an undisclosed financial terms.
• The move complements Emerson’s software and technology portfolio and helps accelerate delivery of life-saving medicines.
• Earlier in 2021 , Emerson had made an equity investment in Fluxa.
• Fluxa accelerates the speed to market for new therapies by helping drug development and manufacturing organizations harness the power of collaboration and data across sites, functions and processes.
• The addition of Fluxa's PKM software will provide customers a unique solution, integrated with Emerson's industry leading DeltaV control system and life sciences automation software, accelerating the development of new drug therapies into production.

For further details see: